Method of treatment of atopic disease
US5709853A · kind A · utility
99Cited by
0References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 3, 1995 |
| Grant date | Jan 20, 1998 |
| Priority date | — |
| Expiry date | Nov 3, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61Q19/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to pharmaceutical composition for atopic disease comprising interferon .beta. as an active ingredient, because it significantly improved dermatic symptoms of atopic dermatitis, decreased the number of blood eosinocytes remarkably which is a main causative factor of allergic reactions, and exhibited a fast-acting and prolonged effect.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.